In patients with end-stage dilated cardiomyopathy (DCM), gp130 and JAK-STAT signaling are altered (57), studies conducted in left ventricular (LV) myocardia pointed out reduced levels of JAK2 phosphorylation and gp130 (57). This evidence concerns the gene SOAT1 and familial dilated cardiomyopathy.